RVNC
Revance Therapeutics Inc
Price:  
3.65 
USD
Volume:  
4,122,600.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RVNC Relative Valuation

-1014.9%
Upside

As of 2025-07-11, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (33.39) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -1014.9%.

The range of the Relative Valuation is (32.16) - (32.86) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.9x - 18.6x 18.4x
Forward P/E multiples 18.2x - 20.7x 19.4x
Fair Price (32.16) - (32.86) (33.39)
Upside -981.0% - -1000.4% -1014.9%
3.65 USD
Stock Price
(33.39) USD
Fair Price

RVNC Relative Valuation - Historical P/E Data

Date P/E